+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CSL Behring - logo

CSL Behring is a global leader in the plasma protein biotherapeutics industry. It specializes in bleeding disorder, fluid replacement, hereditary angioedema, immunoglobulin, pulmonary, and wound healing biotherapies. Its therapies are being used to treat coagulation disorders, primary immune deficiencies, neurological conditions, inherited respiratory diseases and a variety of others. The company was founded in 2000 and is based in King of Prussia, Pennsylvania.

From
Myositis - Pipeline Insight, 2025 - Product Thumbnail Image

Myositis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Disease Analysis: Hemophilia - Product Thumbnail Image

Disease Analysis: Hemophilia

  • Report
  • June 2021
  • 102 Pages
  • Global
From
From
From
From
Complement C1 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Complement C1 Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
C1 Esterase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

C1 Esterase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Loading Indicator